TY - JOUR
T1 - Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fcγ receptor type III, and Mannose-binding protein in febrile children with cancer and neutropenia
AU - Lehrnbecher, Th
AU - Venzon, D.
AU - De Haas, M.
AU - Chanock, S. J.
AU - Kühl, J.
N1 - Funding Information:
Received 19 November 1998; revised 9 April 1999. The study was conducted under the auspices of the institutional review board of the University of Würzburg, and informed consent was obtained from parents and, when feasible, from patients. Financial support: Dr. Mildred Scheel Stipendium, Deutsche Krebshilfe e.V. (to T.L.). Reprints or correspondence: Dr. Thomas Lehrnbecher, Kinderklinik und Poliklinik der Universität Würzburg, Josef-Schneider-Strasse 2, D-97080, Würzburg, Germany (Lehrnbecher@mail.uni-wuerzburg.de).
Funding Information:
From the Department of Pediatrics, University of Würzburg, Würzburg, Germany; the Pediatric Oncology Branch and Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, U.S.A.; and Central Laboratory of Blood Transfusion, Amsterdam, the Netherlands
PY - 1999
Y1 - 1999
N2 - Circulating levels of interleukin (IL)-6, IL-8, soluble Fcγ receptor type III (sFcγRIII), mannose-binding protein (MBP), and C-reactive protein (CrP) were assessed among febrile children with cancer and neutropenia. Levels of IL-6, IL-8, sFcγRIII, MBP, and CrP were measured in serum from 56 pediatric cancer patients at the time of admission for 121 episodes of febrile neutropenia (88 febrile episodes without identifiable source, 5 clinically documented infections, 20 episodes of bacteremia due to gram- positive and 5 due to gram-negative organisms, and 3 fungal infections). IL- 6 and IL-8 levels were higher in patients with either bacteremia due to gram- negative organisms or fungal infections than in patients with febrile episodes without an identifiable source (P < .00001 for each). IL-6 and IL-8 levels were higher in children with bacteremia due to gram-negative organisms than in those with bacteremia due to gram-positive organisms (P = .0011 and P = .0003, respectively). The measured levels of CrP, MBP, and sFcγRIII were not useful for identifying the type of infection. These preliminary results show the potential usefulness of IL-6 and IL-8 as early indicators for life- threatening infections in febrile cancer patients with neutropenia.
AB - Circulating levels of interleukin (IL)-6, IL-8, soluble Fcγ receptor type III (sFcγRIII), mannose-binding protein (MBP), and C-reactive protein (CrP) were assessed among febrile children with cancer and neutropenia. Levels of IL-6, IL-8, sFcγRIII, MBP, and CrP were measured in serum from 56 pediatric cancer patients at the time of admission for 121 episodes of febrile neutropenia (88 febrile episodes without identifiable source, 5 clinically documented infections, 20 episodes of bacteremia due to gram- positive and 5 due to gram-negative organisms, and 3 fungal infections). IL- 6 and IL-8 levels were higher in patients with either bacteremia due to gram- negative organisms or fungal infections than in patients with febrile episodes without an identifiable source (P < .00001 for each). IL-6 and IL-8 levels were higher in children with bacteremia due to gram-negative organisms than in those with bacteremia due to gram-positive organisms (P = .0011 and P = .0003, respectively). The measured levels of CrP, MBP, and sFcγRIII were not useful for identifying the type of infection. These preliminary results show the potential usefulness of IL-6 and IL-8 as early indicators for life- threatening infections in febrile cancer patients with neutropenia.
UR - http://www.scopus.com/inward/record.url?scp=0032813989&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032813989&partnerID=8YFLogxK
U2 - 10.1086/520224
DO - 10.1086/520224
M3 - Article
C2 - 10476751
AN - SCOPUS:0032813989
SN - 1058-4838
VL - 29
SP - 414
EP - 419
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 2
ER -